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Rab8a interacts directly with PI3Kc to modulate
TLR4-driven PI3K and mTOR signalling
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Toll-like receptor 4 (TLR4) is activated by bacterial lipopolysaccharide (LPS) to mount innate
immune responses. The TLR4-induced release of pro- and anti-inflammatory cytokines
generates robust inflammatory responses, which must then be restrained to avoid disease.
New mechanisms for the critical regulation of TLR-induced cytokine responses are still
emerging. Here we find TLR4 complexes localized in LPS-induced dorsal ruffles on the surface
of macrophages. We discover that the small GTPase Rab8a is enriched in these ruffles and
recruits phosphatidylinositol 3-kinase (PI3Kg) as an effector by interacting directly through its
Ras-binding domain. Rab8a and PI3Kg function to regulate Akt signalling generated by
surface TLR4. Rab8a and PI3Kg do not affect TLR4 endocytosis, but instead regulate
mammalian target of rapamycin signalling as a mechanism for biasing the cytokine profile to
constrain inflammation in innate immunity.
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M
acrophages are key sentinels of the innate immune
system, tasked with detecting and responding to
pathogens. Accordingly, the macrophage cell surface
is armed with various membrane protrusions, is serviced by
multiple endocytic and exocytic pathways and has a high rate of
plasma membrane turnover to accommodate environmental
sampling and pathogen sensing1. Members of the Rab family of
small GTPases regulate multiple steps of membrane trafficking2
and, in macrophages, Rabs associated with the cell surface and
endocytic pathways are uniquely poised to influence pathogen
recognition and internalization3–5. Multiple Rabs are involved in
the phagocytosis of pathogens6,7 and in the trafficking
and secretion of cytokines in pathogen-activated cells1. Several
Rabs3–5 have also been implicated in regulating the trafficking of
Toll-like receptor 4 (TLR4), a member of the TLR family of
pattern recognition receptors that initiate cellular responses to
pathogens and danger signals8.
TLR4 recognizes the lipopolysaccharide (LPS) component of
Gram-negative bacteria and activates macrophages to initiate
responses including the release of inflammatory cytokines and
chemokines, production of reactive oxygen species and modula-
tion of cell survival and proliferation9. The spatiotemporal
regulation of TLR4 and its signalling from either cell surface or
endosomal complexes regulates the net outcome of these
responses10–12. At the cell surface, LPS-bound TLR4 dimerizes
for the phosphoinositide-dependent recruitment of its adaptors,
Mal (TIRAP) and MyD88 (ref. 13), resulting in the activation of
transcription factors, such as NFkB and AP-1, for the production
of inflammatory cytokines14,15. Surface activation of TLR4 also
invokes the phosphatidylinositol 3-kinase (PI3K)/Akt pathway16.
Inhibiting PI3Ks biases TLR-induced cytokine responses
towards a pro-inflammatory setting. Reports have suggested
two mechanisms to explain this effect: the regulation of TLR4
endocytosis10 and the regulation of downstream TSC/mammalian
target of rapamycin (mTOR) signalling16. mTOR, a serine/
threonine protein kinase, is the catalytic subunit for both the
mTORC1 and mTORC2 complexes17. Rapamycin targets the
mTORC1 complex downstream of Akt, and during TLR4
signalling, it selectively increases the production of pro-
inflammatory cytokines16. Collectively, these complex signalling
pathways regulate the inflammatory response, the programming
of which is critical for correctly responding to different pathogens
and for delimiting inflammation. Dysregulated or excessive
cytokine secretion has serious or even fatal consequences in
acute conditions like sepsis, and in chronic inflammatory or
autoimmune diseases18. Importantly, there are multiple
regulatory checkpoints that exert tight control of the TLR4
signalling response; however, the full extent and nature of the
mechanisms underlying this control remain unclear.
First contact with pathogens such as bacteria is initiated at the
cell surface, thus we set out to characterize some of the relevant
membrane domains and cellular machinery involved in
macrophage activation by LPS. Dorsal ruffles are strikingly
upright, and often curved or circular protrusions that accompany
pathogen contact and precede macropinocytosis and phagocy-
tosis in activated macrophages19,20. In other cell types, dorsal
ruffles house growth factor receptors and are sites for initiating
growth factor-induced signalling21,22. However, dorsal ruffles
have received little previous attention with respect to LPS
activation of TLR4 (ref. 19). Screening of Rab GTPases for
ruffle localization in macrophages drew our attention to Rab8a, a
multi-tasking Rab previously localized to leading edges of the cell
surface and endo/exocytic pathways in multiple cell types23. Here
we show that Rab8a and components of the TLR4 complex are
enriched in dorsal ruffles where they contribute to LPS-initiated
signalling. By mass spectrometry and biochemical analysis, we
identified the p110g catalytic subunit of PI3K as a new effector
for Rab8a and thus present, for the first time, a Rab GTPase
that binds directly to a class IB PI3K. Furthermore, we show
a function for this complex in innate immune signalling.
During TLR4 receptor activation, Rab8a and PI3Kg are
together required to fully activate the Akt/mTOR pathway and
bias the cytokine response away from a hyperinflammatory
setting by decreasing the production of pro-inflammatory
cytokines and increasing the production of anti-inflammatory
cytokines. Rab8a and PI3Kg are presented herein as new
regulators of signalling in the TLR4 pathway.
Results
TLR4 and Rab8a in dorsal ruffles of activated macrophages. In
macrophages, peripheral Rac-1 and phosphatidic acid dependent
ruffling occurs constitutively24 and is typically enhanced by
growth factors like colony-stimulating factor-1 (ref. 25). Here we
show that LPS also increases dorsal ruffling on macrophages,
revealing this as an acute macrophage response to contact with
Gram-negative bacteria. F-actin-rich dorsal ruffles protruding
from LPS-activated cells are increased twofold over those in
untreated cells (Fig. 1a and Supplementary Fig. 1a). This mirrors
the observation that ruffles do not form after knockdown of TLR4
(ref. 19). Further examination of ruffles in transfected cells
revealed that both Citrine-labelled TLR4 and its cell surface
adaptor, Mal (as Cerulean-labelled Mal), are enriched in dorsal
ruffles (Fig. 1b), denoting these domains as a new location for the
pathogen recognition receptor complex of TLR4/Mal/MyD88.
Colocalization with Mal places Rab8a in the same ruffles as the
TLR4 complex (Fig. 1c). Moreover, under these conditions, Rab8a
is actively recruited to the ruffles, rather than being present by
passive membrane binding alone. This recruitment can be
demonstrated by ratiometric imaging, which highlights the
dramatic enrichment of full-length Rab8a protein in dorsal
ruffles, compared with the charge-dependent membrane binding
of the polybasic Rab8a tail (Fig. 1d and Supplementary Fig. 1b).
As established locales for receptor signalling, dorsal ruffles are
enriched in signalling phosphoinositides, PI(3,4,5)P3 and
PI(3,4)P2, which can be labelled in live cells with the PH
(pleckstrin homology) domain of Akt (GFP-Akt-PH)26. Our
LPS-activated cells show strong Akt-PH labelling of Rab8a-
containing dorsal ruffles, with both molecules enriched two to
threefold, compared with their labelling in other plasma
membrane domains (Fig. 1e). This membrane localization of
Rab8a is consistent, even at very low expression levels
(Supplementary Fig. 2). Based on Rab8a being enriched in LPS-
induced dorsal ruffles, we next investigated a possible role for
Rab8a in TLR4 signalling.
Rab8a regulates TLR4 signalling and cytokine secretion. To
investigate its function, Rab8a was depleted by small hairpin RNA
(shRNA) in RAW 264.7 macrophages (too30% of control levels)
and cells were treated with LPS to examine downstream signalling
responses (Fig. 2). Rab8a-depleted cells show a modest increase in
phosphorylation of the MAPK protein, p38, but no change in
ERK1/2 phosphorylation or degradation of the NFkB inhibitory
protein, IkB. Notably however, Akt phosphorylation is markedly
reduced (by 460% at 30min) after depletion of Rab8a (Fig. 2a).
To confirm that the altered Akt response could be attributed to
Rab8a, we also examined LPS signalling in cell lines stably
overexpressing Rab8a (by approximately three to four fold) and
found a B2.5-fold increase in Akt phosphorylation at 30 and
60min post LPS (Supplementary Fig. 3a). These results serve to
implicate Rab8a in TLR4 signalling and suggest that Rab8a is
required for maximal PI3K/Akt activation.
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To test the biological significance of Rab8a depletion, we
measured the synthesis and secretion of inflammatory cytokines,
which are initiated downstream of LPS-activated TLR4. Over an
8-hour time course, significantly more pro-inflammatory inter-
leukin-6 (IL-6) is produced at both the transcript and secreted
levels in Rab8a-depleted cells compared with controls (Fig. 2b).
Conversely, the Rab8a-depleted cells display decreased synthesis
and secretion of the regulatory cytokine, IL-10 (Fig. 2b). Thus,
Rab8a functions in Akt/PI3K signalling to produce a selective or
biased cytokine response to TLR4 activation. This is a wholly new
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Figure 1 | Rab8a and TLR4 colocalize in LPS-enhanced dorsal ruffles. (a) Quantification of dorsal ruffling on untreated and LPS-treated RAW 264.7
macrophages. Images of ruffling and parameters for ruffle quantification are shown in Supplementary Fig. 1. The data are analysed by Student’s t-test.
(n¼ 13–20 per group) ***Po0.001. (b) A single stack image from live, LPS-treated (15min) RAW 264.7 cells expressing TLR4-Citrine and Mal–Cerulean
shows colocalization at peripheral ruffles. Low TLR4-citrine labelling has been enhanced in the z-slice view to visualise cell surface TLR4. Original
16-bit levels (532–18722) enhanced levels (1728–10652). (c) Single z-stack (0.19mm slice) image from live cells transfected with Mal–Cerulean and
tdTomato-Rab8a. Upper panel shows first three slices from the base of the cell where Rab8a and Mal colocalize at the cell periphery; lower panel shows the
top three slices of the cell where there is colocalization in dorsal ruffles. (d) RAW 264.7 cells coexpressing full-length tdTomato-Rab8a and the GFP-tail
domain of Rab8a were used to generate ratiometric images to assess Rab8a enrichment at dorsal ruffles. Inset shows 0.6mm z-slice increments. (e) Single
z-slice shown in basal and dorsal views where td-Tomato Rab8a and GFP-Akt-PH colocalize in ruffles after 15min of LPS treatment. Quantification of Rab8a
and the Akt-PH probe (n¼ 5) in ruffles and other membrane domains was measured by one-way analysis of variance, **Po0.01 and; ****Po0.0001,
respectively. Post-test by Dunnett’s multiple comparisons. All images scale bar, 10mm.
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role for Rab8a in TLR4 signalling, and one not readily explained
by the known Rab8a effectors27. We thus set out to identify the
relevant effector(s) or binding partners for Rab8a mediating its
involvement in TLR4 signalling.
PI3Kc is a direct binding partner and effector for Rab8a. To
identify binding partners for Rab8a in macrophages, we performed
GST-Rab8a pull-down experiments using LPS-activated cell
extracts (Fig. 3a). Mass spectrometry analysis revealed a number of
known and novel Rab8a-binding partners (Supplementary
Table 1a). Among them, a prominent but unexpected binding
partner emerged as a band at 120 kDa, which was identified
convincingly by five independent trypsin-digested peptides, each
with 95% confidence (Fig. 3a,b), as the p110g catalytic subunit of
PI3K (Supplementary Tables 1a,b). Expression of the class 1B
PI3Kg is largely restricted to immune cells where it has been
studied in the context of GPCR-dependent neutrophil and
T-cell migration28, although the highest expression has been
reported in myeloid cells, the majority of which are
macrophages29. To confirm the expression of PI3Kg in
macrophages compared with the other class I PI3Ks (a, b and
d), messenger RNA levels were compared by quantitative reverse
transcriptase PCR, and indeed, PI3Kg is both immune-specific and
is the most abundant isoform in macrophages (Supplementary
Fig. 3b). Traditionally for the class 1B PI3K, the p110g catalytic
subunit interacts with the p87 or p101 regulatory subunits and
with the small GTPase Ras for recruitment to GPCRs30,31. The
unexpected binding of PI3Kg by Rab8a deviates from this model,
prompting a more detailed examination to elucidate the nature of
this interaction.
Purified proteins produced in bacterial and insect cells were
then used for in vitro-binding assays to confirm that Rab8a binds
directly to PI3Kg (Fig. 3c), but not to other class I PI3K isoforms
(Supplementary Fig. 3c). Furthermore, other Rabs known to
function in the TLR4 pathway, such as Rab10 (ref. 3) and 11a5, do
not co-immunoprecipitate PI3Kg (Supplementary Fig. 3d). This
direct interaction is enhanced when Rab8a is in its GTP-bound,
active form, as shown by both GTP loading of GST-Rab8a and
the co-immunoprecipitation of PI3Kg by GFP-Rab8a in the
presence of increasing concentrations of a non-hydrolysable GTP
analogue, GTPgS (Fig. 3d,e). These characteristics are consistent
with PI3Kg interacting with GTP-Rab8a as a new class of Rab
effector.
The recruitment of PI3Kg to membranes is sufficient to initiate
its kinase activity, unlike the other class IA PI3K isoforms32. In
other signalling pathways, this recruitment is mediated by Ras
binding directly to the Ras-binding domain (RBD) of PI3Kg30. To
test whether the RBD is similarly responsible for Rab8a binding,
we performed pull-down experiments using the isolated
recombinant RBD from PI3Kg. The RBD could successfully
substitute for full-length protein under the pull-down conditions,
confirming that it is necessary and sufficient for binding to Rab8a
(Fig. 4a). We then utilized the known crystal structures of GTP-
bound Rab8a33 and the co-crystal structure of PI3Kg with Ras34
to produce a homology model of Rab8a/PI3Kg (Fig. 4b). This
model shows a viable alignment of the PI3Kg RBD with the
effector-binding domain of Rab8a and predicts the critical
binding residues on both sides of the interacting surface.
Mutation of either F221 or T232 in the RBD or the I41
residues in the effector-binding domain of Rab8a is sufficient to
reduce interaction of the two proteins in pull-down experiments
(Fig. 4c). These results provide detailed evidence of a direct
interaction between Rab8a and PI3Kg. Rab8a binds to the same
RBD as Ras, and moreover, uses the same critical residues in the
RBD34 for its interaction with PI3Kg. PI3Kg normally binds to
Ras during its recruitment to activated receptor (GPRC or RTK)
complexes. Seeking evidence for such a receptor interaction with
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Figure 2 | Rab8 is required for TLR4-mediated signalling. (a) Representative immunoblot analysis of LPS time course for control (scrambled shRNA) and
Rab8a-shRNA stable RAW 264.7 cell lines. Phosphorylation of Akt, ERK1/2 and p38 was analysed at 30min post LPS by densitometry. All immunoblots
were cropped for presentation; full-length blots are provided in Supplementary Fig. 5. (b) Control (scrambled shRNA) and Rab8a-shRNA stable
RAW 264.7 cell lines were analysed by quantitative reverse transcriptase PCR (qRT–PCR) for transcriptional response and by enzyme-linked
immunosorbent assay for the secretion of the cytokines IL-6 and IL-10. Graphs represent mean±s.e.m. (n¼ 3 each). Time course profiles were analysed
by two-way analysis of variance (ANOVA). For qRT–PCR; ****Po0.0001 for both IL-6 and IL-10. For cytokine secretion ****Po0.0001 for IL-6 and
***Po0.001 for IL-10. Two-way ANOVA were analyzed by Sidak’s post-test for multiple comparisons.
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TLR4 revealed that PI3Kg does not co-immunoprecipitate with
TLR4 (Supplementary Fig. 3e). Taken together, the substitution of
Ras with Rab8a and the recruitment of PI3Kg independently of
TLR4 imply a novel mode for recruitment of PI3Kg in the TLR4
pathway.
We then sought to determine the membrane localization of
Rab8a and PI3Kg. Cotransfected macrophages show diffuse
cytoplasmic labelling of mCherry-PI3Kg, typical of PI3K isoforms.
In LPS-activated cells, PI3Kg is recruited to macrophage ruffles
where it colocalizes with GFP-Rab8a (Fig. 4d). Like all class I PI3K
isoforms, PI3Kg converts PI(4,5)P2 to PI(3,4,5)P3, a function that
is in keeping with the phosphoinositide environment of the Rab8-
positive ruffles (shown in Fig. 1e). Thus we introduce the class IB
PI3Kg as a novel effector for GTP-Rab8a on ruffle membranes.
Next, we further examined this contention by testing whether
PI3Kg, like Rab8a, functions in TLR4 signalling.
PI3Kc depletion effects on TLR4 signalling and inflammation.
As the first of three approaches to explore PI3Kg function, we
used independent small interfering RNAs targeting PI3Kg
(Fig. 5a). For all small interfering RNAs, there was a decrease in
the phosphorylation of Akt after LPS treatment that correlated
with the depletion level of PI3Kg (Fig. 5a). As a second approach,
macrophages were treated with a PI3Kg isoform-specific inhi-
bitor, AS605240 (ref. 35), resulting in reduced phosphorylation of
Akt in a dose-dependent manner (Fig. 5b). As PI3Kg inhibitors
can have off-target effects at higher concentrations, we also used
genetic ablation of PI3Kg in knockout mice to assess its function.
Targeted knockout of the p110g subunit (PI3Kg / ) in the
C57BL/6 mouse background does not affect the expression of
other p110 isoforms (a, b and d)28. Primary bone marrow-
derived macrophages (BMMs) from PI3Kg / and wild-type
mice were challenged with LPS, resulting in 450% decreased
phosphorylation of Akt in PI3Kg-null cells (Fig. 5c). Taken
together, these findings indicate that loss of PI3Kg in LPS-
treated macrophages significantly reduces Akt signalling. This
effect mimics the knockdown of Rab8a (see Fig. 2a,b) and is
consistent with the notion that PI3Kg acts as the Rab8a
effector during TLR4 signalling. We therefore deduce that the
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physiological roles of both Rab8a and PI3Kg are to augment
TLR4-mediated PI3K/Akt signalling.
We also examined the downstream cytokine responses to LPS
in PI3Kg / BMMs, where production of pro-inflammatory
cytokines, IL-6 and IL-12p40, is significantly enhanced in
response to LPS, compared with BMMs from control animals
(Fig. 6a,b). In contrast, the synthesis and release of IL-10 and the
anti-viral type I interferon, IFN-b, are significantly suppressed in
PI3Kg / BMMs. Hence, PI3Kg affects not only signalling, but
also the innate immune responses activated by TLR4 in
macrophages. In keeping with the signalling profiles and with
the role of Rab8a, PI3Kg serves to bias the inflammatory response
by constraining the production of pro-inflammatory cytokines.
PI3Kc does not regulate endocytosis of TLR4. The inter-
nalization of TLR4 (ref. 12) by effectively removing it from the
surface adaptors, Mal and MyD88, is one possible mechanism for
limiting pro-inflammatory signalling10. Since class I PI3Ks are
commonly involved in endocytic pathways36 and Rabs are also
common endocytic regulators37, a plausible mechanism for the
actions of Rab8a/PI3Kg would ostensibly be to regulate the
endocytosis of TLR4. However, testing of known endocytic
pathways in PI3Kg / BMMs revealed no requirement for
PI3Kg in directly regulating FcgR-mediated phagocytosis,
clathrin-mediated transferrin receptor endocytosis or dextran-
labelled macropinocytosis (Supplementary Fig. 4a–c). Thus,
common endocytic pathways in PI3Kg-null mice appear to
operate efficiently. The internalization of TLR4 itself was then
measured by surface immunolabelling and flow cytometry over a
time course of LPS activation. TLR4 is successfully internalized in
PI3Kg / BMMs at the same rate as in control cells (Fig 7a,b).
Hence, PI3Kg is not required to regulate the endocytosis of TLR4
in this context.
PI3Kc mediates cytokine biasing through mTOR. A second
mechanistic explanation for the cytokine bias observed in
Rab8a- and PI3Kg-depleted cells involves the mTORC1 complex,
which acts downstream of PI3K in TLR4 pathways. Within this
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complex, the serine/threonine protein kinase mTOR has been
implicated in the transcriptional and post-translational regulation
of cytokine production and biasing38. In our wild-type BMMs,
inhibition of mTORC1 with rapamycin effectively enhances the
production of pro-inflammatory cytokines, IL-6 and IL-12p40,
while decreasing the levels of IL-10 (Fig. 8a). This is roundly
consistent with the effects of Rab8a and PI3Kg on cytokine
outputs in our experiments, and with findings relating to mTOR
function in the literature16,39. To investigate if PI3Kg regulates
mTOR downstream of TLR4, we analysed the phosphorylation of
Akt and mTOR in LPS-treated wild-type and PI3Kg / BMMs
(Fig. 8b). Quantification revealed a significant reduction in both
Akt and mTOR phosphorylation in the absence of PI3Kg
(Fig. 8b). To investigate the significance of the decreased
mTOR phosphorylation, we tested two canonical mTORC1
substrates, 4E-BP1 and p70S6K, known targets during LPS
stimulation16. In PI3Kg / cells after LPS treatment, the
phosphorylation of p70S6K was reduced to below detectable
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levels, while 4E-BP1 phosphorylation was reduced for the higher
molecular weight isoform. Together, these results confirm a defect
in the PI3K/Akt/mTOR pathway (Fig. 8c). Thus, PI3Kg is
required for efficient activation of mTOR in response to pathogen
recognition by TLR4. Taken together, our data suggest a new role
for PI3Kg during TLR4 signalling and one that is independent of
receptor endocytosis. The recruitment of Rab8a and PI3Kg
during TLR4 activation functions to enhance the mTOR
signalling pathway, effectively polarizing the cytokine response
and limiting inflammation.
Discussion
In this study, we describe a new regulatory unit consisting of
Rab8a with PI3Kg as its effector. In this context, Rab8a plays a
new role in signalling with novel PI3Kg function in the TLR4
pathway. This additional role for PI3Kg extends its reach beyond
known GPCRs and RTKs. In macrophages exposed to LPS, Rab8a
and PI3Kg are recruited to dorsal ruffles along with components
of the TLR4/Mal/MyD88 complex. Rab8a and PI3Kg are two
newly introduced partners that are required for effective
Akt/mTOR signalling during TLR4 activation. PI3Kg serves to
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enhance mTOR phosphorylation and signalling via this arm of
the TLR4 response, whereby downstream proteins can both
constrain inflammatory responses by curtailing production of
pro-inflammatory cytokines and bias the response in favour of
regulatory or anti-inflammatory cytokines38. Our findings thus
reveal the Rab8a/PI3Kg complex as an important and additional
mechanism for controlling PI3K signalling in inflammation.
Rab8a is a ubiquitous Rab, functioning in multiple recycling
pathways through a variety of effectors27,40,41. The Rab8a
localization we show in activated macrophages is broadly
commensurate with its previous localization on cell surfaces, at
leading edges and on membrane vesicles and tubules moving to
and from the surface23,40. Within this distribution, we show a
specific and dramatic recruitment of Rab8a to dorsal ruffles on
the surface of LPS-activated macrophages, along with
components of the surface TLR4 complex. Our study serves to
highlight macrophage dorsal ruffles as a previously unheralded
site for clustering of the TLR4 receptor and associated molecules.
The features we show, namely the recruitment of PI3Kg,
generation of the signalling phosphoinositide PI(3,4,5)P3 and
subsequent activation of Akt, denote these dorsal ruffles as a
functional site for TLR4 signalling. Rab8a enrichment in the
ruffles is striking and reflects the clustering of Rabs at functional
membrane domains, mostly at the behest of their guanine
nucleotide exchange factors and effectors. The identity of such
Rab8a recruitment factors in this locale is not yet known,
although the GTPase Arf6 is a candidate player due to its roles in
ruffle formation42, its deactivation of Rab8a in epithelial cells43
and a proposed role in TLR4 activation in macrophages13. While
Rab8a regulates signalling from the surface TLR4 complex,
additional Rabs influence TLR4 at other points along the
endocytic and recycling pathways via more traditional
trafficking mechanisms. Rab11a regulates recycling endosome-
mediated delivery of TLR4 to phagosomes, an alternative site
proposed for LPS activation of TLR4 wherein TLR4 signals via
the TRIF/TRAM adaptors to produce IFN-b5. Of note is the fact
that phagosomes can be generated from dorsal ruffles, suggesting
perhaps another route for spatiotemporal regulation of TLR4.
Also, Rab10 (ref. 3) and Rab7 (ref. 4) function in recycling of
TLR4 to the surface and for degradation, respectively; however,
Rab effectors relevant to TLR4 at all of these other steps remain
undefined. We now recast Rab8a with a new effector and a very
different role through its direct involvement in PI3K signalling in
the TLR4 pathway.
PI3Kg was revealed herein as an unexpected binding partner
for Rab8a and the first instance of class 1B PI3Ks directly
interacting with a Rab. Rab5 was previously implicated as an
effector for class IA PI3Kb44, although the nature of this
interaction was not characterized. At a molecular level, the
PI3K catalytic subunit p110g is traditionally recruited by binding
directly to Ras, along with a class IB regulatory subunit, and the
Gbg subunit of an activated GPCR complex45. We now confirm
that Rab8a and PI3Kg bind directly to each other, using
homology modelling and mutagenesis of critical residues. Rab8a
binds to two residues in the RBD of PI3Kg that are critical and
necessary for Ras binding to PI3Kg34. Recently, Rho family
GTPases, Rac1 and CDC42, but not Ras, were also shown to
directly interact with class IA PI3Kb through the kinase’s RBD46.
Our findings now show that the PI3K RBD also supports
interactions with a Rab GTPase, in addition to Ras and Rho
family GTPases46. These G protein families thus offer a variety of
modalities for the recruitment and regulation of PI3Ks in
signalling pathways.
In the context of LPS signalling, it remains unclear precisely
how PI3Kg is recruited and activated by TLR4, particularly
because PI3Kg does not bind directly to TLR4. Our findings
suggest that Rab8a provides a parallel means of recruiting a PI3K
to augment LPS signalling, with Rab8a/PI3Kg acting as an
auxiliary unit in its own right or in the context of another
receptor. Such crosstalk for amplifying PI3K-mediated signalling
has precedents, including the FcERI receptor in mast cells, where
this receptor has no direct link to GPCRs, yet degranulation is
dependent on PI3Kg47. Indeed, a seminal study of tumour-
associated macrophages expanded the field of PI3Kg’s influence
by showing that it regulates signalling not only from GPCRs, but
also from RTKs and the TLR/IL1 receptor29. In the complex
ligand environment of tumour inflammation, the loss of PI3Kg
was found to limit tumour progression29, in line with the current
interest in PI3Kg inhibitors for treating cancer. By adding the
pathogen recognition receptor, TLR4, to the classes of receptors
employing PI3Kg, we raise questions for the future about even
more receptors that may activate Rab8a/PI3Kg, including other
members of the TLR family and their arrays of pathogen-derived
ligands. Further studies are also needed to establish whether
Rab8a, rather than Ras, is involved in recruiting PI3Kg to other
receptor families.
Previous studies have focused on TLR4 internalization as a
mechanism by which macrophages can terminate the production
of pro-inflammatory cytokines10–12. The class IA PI3Kd is
recruited to the TLR4 complex, where it reportedly regulates
internalization of the receptor by an unknown pathway10. This
results in a switch from cell surface MyD88/Mal signalling, which
generates pro-inflammatory cytokines, to the endosomal adaptors
TRIF/TRAM, which induce production of type I interferons10.
We saw no general effects on endocytosis or the internalization of
TLR4 itself after loss of PI3Kg. Therefore, Rab8a/PI3Kg operates
via another mechanism to control TLR4 signalling and cytokine
production. The effects we demonstrate here for PI3Kg are
similar to those reported for PI3Kd in enhancing Akt signalling
and in limiting pro-inflammatory cytokines. Therefore, it is likely
that both PI3Ks act in concert to augment the same effect,
possibly reflecting the need for multiple mechanisms to stimulate
and fine-tune the production of inflammatory cytokines.
Mechanistically, we found that Rab8a and PI3Kg exert their
control over cytokine production by signalling through the multi-
functional serine/threonine protein kinase mTOR, which acts as a
hub downstream of TLR4 to strategically bias cytokine
responses48. In this context, mTOR signalling inhibits the
function of NFkB and the transcription of pro-inflammatory
cytokines, IL-6 and IL-12p40, while enhancing the function of
STAT3 and the transcription of an anti-inflammatory or
regulatory cytokine, IL-10 (refs 16,49). The importance of
mTOR in this regulatory role emerged with a recent study
showing that the intracellular pathogen Legionella pneumophila
subverts the immune response with bacterial effectors that target
mTOR to disengage its cytokine biasing role39. The regulation of
mTOR downstream of TLR4 by PI3Kg results in the polarized
inflammatory response towards an anti-inflammatory setting.
This effect has been demonstrated elsewhere, through the
pharmacological inhibition of mTORC1 with rapamycin and by
the genetic perturbation of TSC2—another kinase in the
pathway16. Our findings represent the first example of mTOR
regulation by a Rab GTPase through PI3Kg. Given that mTOR
controls many cellular functions, Rab8a and PI3Kg may have
broader physiological effects beyond cytokine production.
PI3Kg has become an attractive drug target in cancer and other
diseases50. PI3Kg / mice show reduced inflammation in a
number of disease models, including diabetes51 and cardio-
vascular disease52, primarily related to roles for this kinase in
GPCR-dependent cell migration of immune cells and activation
of the respiratory burst28. On this basis, PI3Kg inhibitors are also
viewed as potential anti-inflammatory drugs47. However, at least
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in the context of bacterial infection, our preliminary results
suggest that PI3Kg inhibition might acutely skew signalling
towards pro-inflammatory cytokines, enhancing bactericidal
responses, but exacerbating inflammation. Further studies are
now needed to dissect the role of PI3Kg and the clinical
consequences of its inhibition over the course of bacterial
infection and in disease. As a pharmacologically tractable target
operating at a critical point to regulate cytokine outputs from
TLR4 activation, understanding how PI3Kg influences infection
and inflammatory disease is vital.
Methods
Antibodies and reagents. Primary antibodies recognizing PI3Ka, b, g, d (sampler
kit-9655), phospho-mTOR, phospho-4E-BP, phospho-p70 S6 kinase (sampler
kit-9862), Akt (9272), phospho-Akt (Ser473) (4962), phospho-p38 MAPK (Thr180/
Tyr182) (4511), IkBa (9242), phospho-ERK1/2 (4370) were purchased from Cell
Signaling Technology (Beverly, MA, USA). Mouse anti-Rab8 (610845) was
purchased from BD Transduction Laboratories (Lexington, KY, USA). GST
antibody (71-7500) was purchased from Invitrogen, Sydney, Australia. Anti-TLR4
for western blotting was from Abcam (ab22048). For fluorescent-activated cell
sorting (FACS) analysis, the anti-TLR4 SA15-21 clone was biotinylated using the
EZ-Link Micro Sulfo-NHS-LC-Biotinylation Kit (Thermo Scientific, CA, USA).
Streptavidin–APC (Biolegend, CA, USA) was used to detect biotinylated anti-
TLR4. Mouse anti-glyceraldehyde-3-phosphate dehydrogenase (2275-PC-1) was
purchased from Trevigen (Gaithersburg, MD, USA). Alexa Fluor 488/594-
(A21208) and 647- (A31573) conjugated secondary antibodies, Alexa Fluor
488- and 647-dextran and wheat germ agglutinin (WGA)-Texas Red were pur-
chased from Molecular Probes (Invitrogen, OR, USA). Horseradish peroxidase-
conjugated goat anti-mouse and rabbit antibodies (81–6520) were obtained from
Zymed (San Francisco, CA, USA). Bacterial lipopolysaccharide (LPS), purified
from Salmonella enterica serotype Minnesota Re 595, was purchased from Sigma-
Aldrich (Castle Hill, NSW, Australia). AS605240 (IC50¼ 0.008 mM) was purchased
from Sigma-Aldrich and IC87114 (IC50¼ 0.07 mM) was from Scientifix, Australia.
For phagocytosis, human IgG (Invitrogen) was conjugated to 3 mm latex beads
(Sigma). All other chemicals and reagents were from Sigma-Aldrich.
Plasmid and constructs. The mouse PI3Kg cDNA was obtained from the Facility
for Life Science Automation at the Institute for Molecular Bioscience. GST-PI3Kg-
FL and His-PI3Kg-FL were expressed in Sf9 insect cells using baculovirus expres-
sion vector systems according to the manufacturer’s instructions (Invitrogen).
Rab8a was subcloned into pEGFP-C1, pm-Cherry-C1 and ptd-Tomato-C1 that had
been generated from pCMV-tdTomato (Clontech). The pEGFP-Rab8aCAAX
domain (Rab8a tail) was generated by PCR to contain the last 29 amino acids of the
Rab8a C terminus with a modification of the CAAX motif to CMIV to allow for
prenylation of the fusion protein53,54. Rab8a was also subcloned into pGEX6P-1 and
expressed in E. coli55. Phosphoinositide probes and pEGFP-C1-Akt-PH were
kindly provided by Frederic Meunier, and the lentiviral vector PLL5.0 was obtained
from Alpha Yap (both of The University of Queensland, QLD, Australia).
Mal–Cerulean and TLR4-Citrine plasmids were gifts from Nicholas J. Gay,
University of Cambridge, UK.
Expression and purification of recombinant proteins. Recombinant GST-tagged
proteins were produced in an E. coli BL21(DE3) strain transformed with the
plasmid DNA of interest. Expression of the recombinant protein was induced with
the addition of 0.5mM IPTG for 18 h at 25 C with shaking. The bacterial cells
were then pelleted by centrifugation at 5,000g. The pellets were resuspended in ice-
cold lysis buffer (Tris pH 7.4, 300mM NaCl, 1mM EDTA, cOmplete EDTA-free
protease inhibitor cocktail tablet (Roche Applied Science), 1mM DTT and 1mM
PMSF). The bacterial lysates were lysed using a Constant Systems cell disruptor
according to the manufacturer’s instructions (Thermo Scientific, Australia) and
then cleared by centrifugation at 48,254g at 4 C. The recombinant proteins were
affinity purified by incubating the cleared lysate with Glutathione Sepharose
(GE Healthcare Life Science, Australia) for 1 h at 4 C. The beads were washed
extensively with 1M NaCl in 20mM Tris pH 7.4. GST-fusion proteins on the beads
were stored at  20 C in 20mM Tris pH 7.4 containing 20% glycerol.
Mouse model. Knockout of the p110g subunit in PI3Kg / mice (pik3cg2/2) on a
C57BL/6 background has been previously described28. Age (16–20 weeks) and sex-
matched C57BL/6 mice were used as controls. Mice were housed and used for
experiments in accordance with approved animal ethics protocols at AMREP (Alfred
Medical Research and Education Precinct) AEC, Alfred Hospital Melbourne,
Victoria. (E/1089/2011/M). Experiments utilized samples or cells from three or more
mice per group per time point to generate statistical significance. Animals within
groups were randomized for treatments. Primary BMMs were obtained by ex vivo
differentiation of bone marrow cells collected from mouse femurs or tibias. Cells
were differentiated for 7 days in complete RPMI medium supplemented with
20Uml 1 penicillin, 20mgml 1 streptomycin and 100 ngml 1 purified
recombinant macrophage colony-stimulating factor-1 (refs 56,57).
Cell culture and siRNA. The mouse RAW 264.7 macrophage cell line was sourced
from ATCC. PI3Kg was silenced using Stealth siRNA primer sets from Life
Technologies, Australia (catalogue number 1320003). RAW 264.7 macrophages
were cultured in RPMI 1640 medium (Lonza) supplemented with 10% heat-
inactivated FCS (Thermo Trace) and 2mM L-glutamine (Invitrogen) in humidified
5% CO2 at 37 C (ref. 58). Cells were screened monthly for mycoplasmal
contamination. For transient expression of cDNA, cells at 50% confluence were
transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions. Cells were typically used for experiments 18 h after transfection. Non-
targeting siRNA was used as a control. For Rab8a depletion, an 18 nucleotide
shRNA was designed and cloned into the lentivirus expression vector LentiLox
pLL5.0 (refs 59–61), using forward primer 50-tGCCTTCAACTCCAC ATT
CAttcaagagaTGAATGTGGAGTTGAAGGCttttttg-30 , and reverse primer 50-TCG
ACAAAAAAGCCTTCAACTCCACATTCATCTCTTGAATGAATGTGGATTG
AAGGCA-30 . The shRNA was cloned downstream of the U6 promoter (HpaI and
XhoI) into a lentivirus expression vector pLL5.0 (backbone pLL3.7) carrying a
soluble mCherry gene as a fluorescent reporter. The pLL5.0 shRNA and packaging
vectors were transfected into HEK-293T cells by Lipofectamine 2000 precipitation.
Virus-like particles were collected from the supernatant 48–72 h after transfection,
and virus was concentrated using polyethylene glycol 6000 (ref. 62). Aliquots of
virus were subsequently used for titration or stored at  80 C. Titres were
determined by infecting HEK-293T cells with serial dilutions of concentrated
lentivirus. RAW 264.7 macrophages were infected with lentiviral particles at a
multiplicity of infection of 10 per cell. Cells were incubated at 37 C with lentivirus
in RPMI complete medium and collected 48 h post infection. Single-cell
suspensions were sorted by flow cytometry according to moderate to high levels of
reporter gene expression.
Fixed cell ruffle quantification and analysis. RAW 264.7 macrophages were
grown on coverslips overnight at a low confluency. Cells were either treated with
exogenous LPS 100 ngml 1 (stimulated) or not treated (unstimulated) for 30min
before fixation. Cytoskeletal F-actin was labelled with Alexa Fluor 488 phalloidin
(Life Technologies) for 60min; in addition, nuclei were labelled with 4’,6-diami-
dino-2-phenylindole (DAPI) concurrently. Three-dimensional z-stacks were
acquired using a DeltaVision devolution microscope (GE Healthcare) and were
analysed using Fiji image software. The mid-point of cellular nuclei (DAPI) was
selected and labelled as the new base slice. Slices from the mid-point until the top
of the cell were flattened using maximum projection. Background subtraction and
median filters were applied to the flattened image for smoothing purposes for
further analysis. The image was then duplicated, whereby a threshold mask was
constructed (equally for all images) and all regions collected from the phalloidin
threshold image were selected as the region of interest (ROI). The fluorescence
intensity for the generated ROI in the phalloidin channel was then measured and
quantified using GraphPad Prism.
Phagocytic assay and procedures. Wild-type and PI3Kg / BMMs (n¼ 3
each) were grown on coverslips before phagocytosis experiments. Latex beads
(3 mm diameter) from Sigma-Aldrich (LB30-2ML) were diluted 1 10 1 in dH2O
and washed with phosphate-buffered saline (PBS) three times by centrifugation.
Beads were resuspended in 2 mgml 1 human immunoglobulin G (IgG) (Invitro-
gen, 02-7102) in PBS. IgG was left to bind by passive adsorption for 2 h at room
temperature on a rotating mixer. The suspension was then washed three times and
resuspended in PBS and sodium azide (0.2%). For phagocytosis, 1 ml of this
suspension was added to macrophages on coverslips in 1ml of cold complete
RPMI medium, and spun onto the cells at 1,00g for 2min at 4 C. Cells are then
transferred back to 37 C for 5–20min. Cells were fixed in 4% paraformaldehyde
for 30min and then permeabilized, if required, with 0.1% Triton X-100/PBS for
5min. Washing, blocking and antibody incubation steps were done using blocking
buffer (0.5% BSA/PBS). Human IgG on beads was detected using Cy3 goat anti-
human antibody (1:200, Jackson Labs 109-165-003). Cells were labelled with
Alexa350/488 phalloidin (1:50/1:500, Molecular Probes, 22281,12379), to outline
cells and show actin-enrichment at sites of phagocytosis. Coverslips were mounted
in Prolong Gold (Invitrogen, P10144) for imaging. Olympus BX-51 upright
microscope fitted with an Olympus DP-71 12Mp Colour Camera. Images were
captured using a  40/1.35 U Apo Oil lens with the Olympus DP controller
version 2.1 capture software at an image size of 2040 1536 pixels. Each bead was
classified as either phagocytosed (Cy3o5%), in-between (5%oCy3o95%) or
attached (Cy3 495%) for comparison between groups63. (n4200 beads per
animal).
TLR4 internalization assay. Wild-type and PI3Kg / BMMs (n¼ 3 each) were
grown on non-adherent tissue culture plates. In FACS tubes, 0.5 106 cellsml 1
for each animal in triplicate were treated with or without LPS (100 ngml 1) for
indicated times at 37 C before being placed on ice to halt all internalization. Cells
were washed twice with ice-cold FACS buffer (PBS, 1% FCS, 5mM EDTA) and
blocked with 24G2 for 20min on ice. Cell surface TLR4 was stained with
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biotinylated anti-TLR4 (clone SA15-21 Biolegend 145402) at 0.5 mg ml 1. Cells
were washed three times in FACS buffer before labelling with Streptavidin–APC
(Biolegend 405207) at 0.5 mgml 1. Cells were washed extensively in FACS buffer
at 4 C before acquisition on a Canto II cytometer (Becton Dickinson). Cellular
profiles were analysed using FlowJo software (TreeStar). The percentage
internalization¼ (MFIXMFITLR4 / )/(MFIWT untreatedMFITLR4 / ) 100
for each data point.
Transferrin uptake assay. Wild-type and PI3Kg / BMMs (n¼ 3 each) grown
on coverslips were serum starved for 30min and treated with Alexa Fluor 546-
labelled mouse transferrin (Life Technologies) for 10min at 37 C. Cells were then
washed and chased for 20min at 37 C in complete medium to allow trafficking of
transferrin from early endosomes to recycling endosomes. Flattened three-
dimensional images were captured for each treatment using identical conditions.
The background intensity ROI was selected from a region not containing cells.
Background intensity was removed from the entire field of view before individual
cells were selected, and total cell transferrin intensity was then measured for
analysis (n430 cells per animal).
Dextran uptake assay. RAW 264.7 macrophages were incubated with or without
LPS pre-priming for 30min. Alexa Fluor 488-conjugated dextran (10,000 MW) was
added to the cells at a final concentration of 50 mgml 1 in complete medium and
left on cells for 10min. Macropinocytosis was stopped by washing cells in 4 C PBS
before exchanging for 4 C complete medium. Cells were kept on ice until imaging
live using the Personal DeltaVision deconvolution microscope. Macropinocytosis
was then analysed using ImageJ software. Cells were segmented using WGA as a
cell mask. Macropinosomes were segmented and filtered by size 40.2 mm. Final
segmentation of individual macropinosomes was performed manually before
counting and size measurements were taken in an automated fashion.
Ruffle enrichment analysis. Recruitment analysis was performed by comparing
the fluorescence intensity of a transfected protein at multiple locations in a given
cell. The peak fluorescence intensity of each channel across an ROI line was divided
by the fluorescent intensity of WGA as a measure of total membrane. The mean
fluorescence of each channel/WGA at the filopodia was set to 1 and the mea-
surements in ruffles compared with identify recruitment of tdTomato-Rab8a and
GFP-Akt-PH. By standardizing all measurements to the WGA intensity at the
filopodia, measurements among cells could be compared even though the total
intensity per cell was not equal.
Microscopy. For live cell experiments, RAW 264.7 macrophages were cultured on
glass-bottom 35-mm dishes (MatTek). Live and fixed cell imaging were addition-
ally performed using a Personal DeltaVision Olympus IX71 inverted wide-field
deconvolution microscope equipped with Olympus U-Apochromat 40 /1.35 oil
DIC, Plan-Apochromat 60 /1.42 oil DIC and UPLS-Apochromat 100 /1.40 oil
DIC, and a 120W xenon arc lamp. Images were captured using a Roper Coolsnap
HQ2 monochrome camera. Live cell three-dimensional z-stack imaging for ruffle
analysis using temporal colour coding was acquired using the Zeiss Axiovert 200
Yokogawa spinning disk confocal microscope. Each stack was acquired every 30 s
and full stacks represented as sum-intensity projections. Temporal colour coding of
each slice was performed using ImageJ and the spectrum lookup table. Immuno-
fluorescence staining is described in ‘phagocytic assay and procedures’63,64.
Scanning electron microscopy. RAW 264.7 macrophage cells were incubated
with human IgG-opsonized latex beads (3 mm, Sigma-Aldrich) for 30min and fixed
with 2.5% glutaraldehyde in sodium cacodylate buffer, post-fixed in 2% osmium
tetroxide, dehydrated through ethanol, and dried using HMDS (Sigma-Aldrich).
Coverslips were coated in platinum and viewed on a JEOL JSM-6300F scanning
electron microscope.
Immunoblot. For immunoblot analysis65, cells were lysed in lysis buffer (20mM
HEPES pH 7.4, 100mM NaCl, 1% NP-40 (Sigma) with addition of 1mM PMSF,
1mM DTT, cOmplete protease inhibitors (Roche Applied Science) and phospho-
Stop tablets (Roche Applied Science). The proteins were transferred to a
polyvinylidene difluoride membrane (BioTrace, NZ), blocked with 5% skim milk in
PBS-0.1% Tween-20 buffer (TBS-T) and incubated overnight at 4 C with primary
antibodies. After washing of the membrane, a secondary antibody was incubated
for 1 hour. The membrane was developed with a chemiluminescence reagent
(ECL, Detection Reagents, Thermo Scientific) according to the manufacturer’s
instructions.
Quantitative real-time PCR and enzyme-linked immunosorbent assay. Total
RNA was prepared using RNeasy mini-kits (Qiagen, Valencia, CA) and cDNA
reverse transcribed using 1 mg of total RNA and Superscript III reverse tran-
scriptase (Invitrogen, Carlsbad, CA). Gene expression was quantitated using SYBR
Green PCR master mix (Applied Biosystems)66, using an ABI Prism 7000 sequence
detection system (Applied Biosystems, Foster City, CA). All primers used in this
study are listed in Supplementary Table 2. Data are presented as relative change
compared with control cells (n¼ 3) and represents the average±s.e.m.
Rab8a GTP loading for GST pull-down and mass spectrometry analysis. GTP-
loaded GST-Rab8a sepharose beads were incubated with LPS-activated cell lysate
for 1 h at 4 C with agitation. MicroSpin columns (#27– 3565–01; GE Healthcare)
were used for all of the pull-downs. Beads were washed with ice-cold wash buffer
(50mM Tris, 150mM NaCl, 1% NP-40, 1mM PMSF, 1mM DTT, pH 7.4). Elution
was achieved conventionally by boiling in 3 SDS–PAGE sample buffer for
5min (ref 67). LC MS/MS was performed at the IMB Mass Spectrometry Facility,
The University of Queensland. LPS-stimulated RAW 264.7 macrophage extracts
were lysed in ice-cold lysis buffer (20mM HEPES pH 7.4, 150mM NaCl, 1% NP-40
(Sigma), 1mM PMSF, 1mM DTT, cOmplete protease inhibitors (Roche Applied
Science), and PhosStop tablet (Roche Applied Science). The lysate was centrifuged
at 75,600 g for 15min at 4 C. The supernatant was pre-cleared by the addition of
GSH-Sepharose beads for 1 h, pelleted at 50 g for 5min at 4 C, and the supernatant
collected. Various GST-tagged recombinant proteins were then incubated with an
equal amount of tissue lysate at 4 C for 1 h. Beads were washed extensively with
ice-cold 20mM Tris pH 7.4 containing 150mM NaCl, 1mM DTT, and 1mM
PMSF, eluted in 2 SDS–PAGE sample buffer, resolved on 10% SDS–PAGE gels,
and stained with Coomassie blue G250. GTP loading of Rab8 was performed by
nucleotide exchange as described earlier68.
Samples were analysed by LC MS/MS on a Shimadzu Prominence Nano HPLC
(Japan) coupled to a Triple TOF 5600 mass spectrometer (ABSCIEX, Canada)
equipped with a nano electrospray ion source. Six microliters of each extract was
injected onto a 50mm 300mm C18 trap column (Agilent Technologies,
Australia) at 30 ml min 1. The samples were de-salted on the trap column for
5min using 0.1% formic acid at 30ml min 1. The trap column was then placed
in-line with the analytical nano HPLC column, a 150mm 75 mm 300SBC18,
3.5 mm (Agilent Technologies, Australia) for mass spectrometry analysis. Linear
gradients of 1–40% solvent B over 35min at 300 nlmin 1 flow rate, followed by a
steeper gradient from 40 to 80% solvent B in 5min were used for peptide elution.
Solvent B was held at 80% for 5min for washing the column, and then returned to
1% solvent B for equilibration before the next sample injection. Solvent A consisted
of 0.1% formic acid and solvent B contained 90/10 acetonitrile/0.1% formic acid.
The ion spray voltage was set to 2400V, declustering potential (DP) 100V, curtain
gas flow 25, nebuliser gas 1 (GS1) 12, and interface heater at 150 C. The mass
spectrometer acquired 500ms full scan TOF-MS data followed by 20 by 50ms full
scan product ion data in an information dependent acquisition (IDA) mode. Full
scan TOF-MS data were acquired over the mass range 350–1400 and for product
ion ms/ms 80–1400. Ions observed in the TOF-MS scan exceeding a threshold of
100 counts and a charge state of þ 2 to þ 5 were set to trigger the acquisition
of product ion, ms/ms spectra of the resultant 20 most intense ions. The data were
acquired and processed using Analyst TF 1.6.1 software (ABSCIEX, Canada).
Proteins were identified by database searching usingProteinPilot v4.5 (ABSCIEX,
Canada) against the UniProt_Sprot_20130205 database (B106,000 entries of all
species searched, FDR of 1%). Search parameters were defined as a thorough search
using trypsin digestion, iodoacetamide cysteine alkylation and all entries in the
database. Proteins were considered identified if there was at least one peptide
identified with 99% confidence.
Image analysis software. All images were analyzed using either ImageJ (version
1.43; National Institutes of Health, Maryland, USA) or Imaris (version 7.3.6, Bit-
plane Scientific Software). Adobe Photoshop CS6 was used to crop regions of
interest or to extract single channels.
Statistics. If not stated otherwise, data are presented as arithmetic means±s.e.m.
For direct comparison of one experimental variation, Student’s t-test was used for
data with normal distribution (assessed by Shapiro–Wilk test). Post-test analysis of
one-way analysis of variance was corrected for multiple comparisons by Dunett’s
method and corrected for multiple comparisons in two-way analysis of variance
using Sidak’s method. All analysed experiments used biological replicates to
compute statistical significance. In all statistical analysis, a P-valueo0.05 was
considered statistically significant. Statistics were calculated using GraphPad Prism
version 7.0 (GraphPad Software, San Diego, CA).
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